Abstract
Isolated hepatic metastases from non‐colorectal primary tumors are rare. Patients with neuroendocrine tumors have an indolent biology compared with other non‐colorectal histologies. This article discusses the surgical management options for patients with neuroendocrine liver metastases and, separately, for those with non‐colorectal, non‐neuroendocrine metastases. Emphasis is placed on the importance of patient selection, understanding the tumor biology and response to systemic therapy. J. Surg. Oncol. 2014 109:8–13.